CAS 2486-75-1 - China Manufacturers, Suppliers, Factory

CAS 2486-75-1, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Amino-2-Methylbenzoic Acid CAS 2486-75-1 Tolvaptan Intermediate Factory
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.10.04 02:47:33
2022.08.29 08:06:59
2021.12.30 14:19:34
2021.12.11 14:24:05
2021.12.05 13:39:15
2021.11.01 17:41:05

CAS 2486-75-1 - China Manufacturers, Suppliers, Factory

Related Products

4-Amino-2-Methylbenzoic Acid CAS 2486-75-1 Tolvaptan Intermediate Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

1,1,3,3-Tetramethyldisiloxane TMDSO CAS 3277-26-7 Purity >99.0% (GC)

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Thiophene CAS 110-02-1 Purity ≥99.9% (GC) Factory High Quality

3,4-Difluorophenylacetic Acid CAS 658-93-5 Purity >99.0% (GC) Factory

Dibenzothiophene CAS 132-65-0 Purity >99.0% (GC) Factory High Quality

Boc-D-Glu-OH CAS 34404-28-9 Assay >99.0% (HPLC)

Cyanamide 50% in H2O CAS 420-04-2 Factory High Quality

D-(-)-Lactic Acid CAS 10326-41-7 Assay 89.0%~91.0% Optical Purity ≥98.0% High Purity

Methyl 3-Oxoheptanoate CAS 39815-78-6 Purity >99.0% (GC)

H-Phe-OtBu·HCl CAS 15100-75-1 Purity >99.0% (HPLC) Factory

4-Iodobenzoic Acid CAS 619-58-9 Assay ≥99.0% (HPLC) Factory

5-Hydroxyoxindole CAS 3416-18-0 Purity ≥95.0% High Quality

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Yellow phosphorus and phosphoric acid rose together

New COVID treatments offer hope

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Xi presents award to top scientists

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.10.04 02:47:33

2022.08.29 08:06:59

2021.12.30 14:19:34

2021.12.11 14:24:05

2021.12.05 13:39:15

2021.11.01 17:41:05

related search